JARSX
Price
$14.95
Change
+$0.18 (+1.22%)
Updated
Apr 24 closing price
Net Assets
253.94M
MGLIX
Price
$15.77
Change
+$0.13 (+0.83%)
Updated
Apr 24 closing price
Net Assets
2.19B
Ad is loading...

JARSX vs MGLIX

Header iconJARSX vs MGLIX Comparison
Open Charts JARSX vs MGLIXBanner chart's image
Easterly Global Real Estate R6
Price$14.95
Change+$0.18 (+1.22%)
VolumeN/A
Net Assets253.94M
MFS Global Real Estate I
Price$15.77
Change+$0.13 (+0.83%)
VolumeN/A
Net Assets2.19B
JARSX vs MGLIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JARSX vs. MGLIX commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JARSX is a Buy and MGLIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
MGLIX has more cash in the bank: 2.19B vs. JARSX (254M). JARSX pays higher dividends than MGLIX: JARSX (2.87) vs MGLIX (2.61). JARSX was incepted earlier than MGLIX: JARSX (8 years) vs MGLIX (16 years). JARSX (1.19) is less costly to investors than MGLIX (0.95). JARSX is a more actively managed with annual turnover of: 141.00 vs. MGLIX (48.00). JARSX (0) and MGLIX (0) have matching initial minimum investment requirements. JARSX annual gain was more profitable for investors over the last year : 11.93 vs. MGLIX (2.35). MGLIX return over 5 years is better than : 21.58 vs. JARSX (14.98).
JARSXMGLIXJARSX / MGLIX
Total Expense Ratio0.950.94101%
Annual Report Gross Expense Ratio1.190.95125%
Fund Existence8 years16 years-
Gain YTD3.159-2.494-127%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets254M2.19B12%
Annual Yield % from dividends2.872.61110%
Returns for 1 year11.932.35508%
Returns for 3 years-13.82-21.1665%
Returns for 5 years14.9821.5869%
Returns for 10 yearsN/A19.21-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TOCQX43.02N/A
N/A
Tocqueville
JFNAX63.90N/A
N/A
Janus Henderson Global Life Sciences A
GMVRX14.37N/A
N/A
Goldman Sachs Small/Mid Cap Value R
NSFOX10.22N/A
N/A
Natixis Target Retirement 2065 N
GTDIX33.14N/A
N/A
Invesco EQV Emerging Markets All Cap R5